L-α-Lysophosphatidylinositol meets GPR55: A deadly relationship

Trends in Pharmacological Sciences

Volumn 32, Issue 5, 2011, Pages 265-269

  Ross, Ruth A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GPR55 PROTEIN; LEVO ALPHA LYSOPHOSPHATIDYLINOSITOL; PHOSPHOLIPID; RHO KINASE; UNCLASSIFIED DRUG;

ARTICLE; BONE CANCER; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER PAIN; CANCER RECURRENCE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; GLIOBLASTOMA; HUMAN; NEUROPATHIC PAIN; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 79955716430     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2011.01.005     Document Type: Review

References (43)

1. Y. Xiao Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses Ann. N. Y. Acad. Sci. 905 2000 242 259 (Pubitemid 30255422)
2. Z.Z. Shen Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases Gynaecol. Oncol. 83 2001 25 30
3. R. Suthphen Lysophospholipids are potential biomarkers of ovarian cancer Cancer Epidemiol. Biomarkers Prev. 13 2004 1185 1191
4. M. Falasca, and D. Corda Elevated levels and mitogenic activity of lysophosphatidylinositol in k-ras-transformed epithelial cells Eur. J. Biochem. 221 1994 383 389 (Pubitemid 24120583)
5. M. Falasca Release of the mitogen lysophosphatidylinositol from H-Ras-transformed fibroblasts; a possible mechanism of autocrine control of cell proliferation Oncogene 16 1998 2357 2365 (Pubitemid 28226883)
6. M. Falasca Changes in the levels of glycerophosphoinositols during differentiation of hepatic and neuronal cells Eur. J. Biochem. 241 1996 386 392 (Pubitemid 26356824)
7. M. Falasca Fast receptor-induced formation of glycerophosphoinositol-4- phosphate, a putative novel intracellular messenger in the Ras pathway Mol. Biol. Cell 8 1997 443 453 (Pubitemid 27171294)
8. M. Falasca Signalling pathways involved in the mitogenic action of lysophosphatidylinositol Oncogene 10 1995 2113 2124
9. M. Stähle Mechanisms in LPA-induced tumor cell migration: critical role for phoshorylated ERK J. Cell Sci. 116 2003 3835 3846 (Pubitemid 37185312)
10. M. Sawzdargo Identification and cloning of three novel human G protein-coupled receptor genes GPR52, psi-GPR53, and GPR55: GPR55 is extensively expressed in human brain Mol. Brain Res. 64 1999 193 198 (Pubitemid 29052470)
11. E. Ryberg The orphan receptor GPR55 is a novel cannabinoid receptor Br. J. Pharmacol. 152 2007 1092 1101 (Pubitemid 350166046)
12. J.E. Lauckner GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current Proc. Natl. Acad. Sci. U.S.A. 105 2008 2699 2704 (Pubitemid 351520576)
13. R.A. Ross The enigmatic pharmacology of GPR55 Trends Pharmacol. Sci. 30 2009 156 163
14. T. Nevalainen, and A.J. Irving GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity? Curr. Top Med. Chem. 10 2010 799 813
15. H. Sharir, and M.E. Abood Pharmacological characterization of GPR55, a putative cannabinoid receptor Pharmacol. Ther. 126 2010 301 313
16. P. Kelly Biological functions of the G12 subfamily of heterotrimeric G proteins: growth, migration, and metastasis Biochemistry 46 2007 6677 6687 (Pubitemid 46906399)
17. J. Juneja, and P.J. Casey Role of G12 proteins in oncogenesis and metastasis Br. J. Pharmacol. 158 2009 32 40
18. 13-mediated signalling in mammalian physiology and disease Trends in Pharmacol. Sci. 29 2009 582 589
19. S. Oka Identification of GPR55 as a lysophosphatidylinositol receptor Biochem. Biophys Res. Commun. 362 2007 928 934 (Pubitemid 47390663)
20. 2+ signaling and NFAT activation FASEB J. 23 2008 183 193
21. A. Kapur Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands J. Biol. Chem. 284 2009 29817 29827
22. S. Oka 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55 J. Biol. Chem. 145 2009 13 20
23. L.S. Whyte The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo Proc. Natl. Acad. Sci. U.S.A. 106 2009 16511 16516
24. S. Oka Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells J. Biol. Chem. 147 2010 671 678
25. L.A. Ford A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells Br. J. Pharmacol. 160 2010 762 771
26. C. Andradas The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK Oncogene 30 2011 245 252
27. R. Piñeiro The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation Oncogene 30 2011 142 152
28. B.D. Robinson Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination Clin. Cancer Res. 15 2009 2433 2441
29. N. Hevir Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines Chem. Biol. Interact. 2010 10.1016/j.cbi.2010.12.013
30. S. Etienne-Manneville Polarity proteins in migration and invasion Oncogene 27 2008 6970 6980
31. D.R. Croft, and Olson MF Regulating the conversion between rounded and elongated modes of cancer cell movement Cancer Cell 14 2008 349 351
32. N.M. Luger Bone cancer pain: from model to mechanism to therapy J. Pain Sympt. Manage 29 2005 32 46
33. P.C. Staton The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain Pain 139 2008 225 236
34. O. Tonyali The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives Expert Opin. Pharmacother. 11 2010 2715 2725
35. A. Bondarenko GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells Br. J. Pharmacol. 161 2010 308 320
36. J.A. Nemeth αV Integrins as therapeutic targets in oncology Cancer Invest. 25 2007 632 646
37. 2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression J. Cell Sci. 121 2008 1704 1717
38. X. Zhang Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator Br. J. Pharmacol. 160 2010 1583 1594
39. Ho WSV Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55? Br. J. Pharmacol. 160 2010 1580 1582
40. R. Lappano, and M. Maggiolini G protein-coupled receptors: novel targets for drug discovery in cancer Nat. Rev. Drug Discov. 10 2010 47 60
41. + channels TREK-1 and TRAAK J. Biol. Chem. 275 2000 10128 10133 (Pubitemid 30202065)
42. M. Monet Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation Biochim. Biophys. Acta 1793 2009 528 539
43. C. Gutierrez, and R. Schiff HER2: biology, detection, and clinical implications Arch. Pathol. Lab. Med. 135 2011 55 62